Evidence map›Paper›PMID 42004198›Full record

ReviewJGH open : an open access journal of gastroenterology and hepatology2026

Magnetic Resonance Enterography Predicts Long-Term Outcomes in Crohn's Disease: A Systematic Review and Meta-Analysis.

Shanshan Wu, Jiayi Yang, Seniu Jizhi, Aniu Liu, Xingyu Chen, Zhonglu Chen, Shumei Zheng

Abstract readReview
In one paragraph

Review in JGH open : an open access journal of gastroenterology and hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shanshan WuDepartment of Gastroenterology and Hepatology The General Hospital of Western Theater Command Chengdu China.ORCID https://orcid.org/0009-0001-4215-6690
Jiayi YangDepartment of Radiology The Affiliated Wuxi People's Hospital of Nanjing Medical University Jiangsu China.ORCID https://orcid.org/0000-0002-5282-1092
Seniu JizhiDepartment of Gastroenterology and Hepatology The General Hospital of Western Theater Command Chengdu China.
Aniu LiuDepartment of Gastroenterology and Hepatology The General Hospital of Western Theater Command Chengdu China.ORCID https://orcid.org/0009-0004-8997-6356
Xingyu ChenDepartment of Gastroenterology and Hepatology The General Hospital of Western Theater Command Chengdu China.ORCID https://orcid.org/0009-0001-4251-7804
Zhonglu ChenDepartment of Gastroenterology and Hepatology The General Hospital of Western Theater Command Chengdu China.ORCID https://orcid.org/0009-0008-3629-2486
Shumei ZhengDepartment of Gastroenterology and Hepatology The General Hospital of Western Theater Command Chengdu China.ORCID https://orcid.org/0000-0002-4463-9784

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Crohn's disease (CD) is characterized by chronic transmural inflammation, which often leads to bowel damage. While mucosal healing (MH) is an established treatment target, transmural healing (TH) has emerged as a more comprehensive goal. Magnetic resonance enterography (MRE) provides excellent soft-tissue resolution for assessing TH. This meta-analysis evaluates the prognostic value of MRE in predicting surgery, hospitalization, and treatment escalation in adults with CD. Methods: A total of 16 studies involving adult CD patients with ≥ 12 months of follow-up (with a mean duration of 4.42 ± 3.90 years) were included if they incorporated pre- and posttreatment MRE, reported baseline MRE phenotypes (e.g., penetrating/stenosing lesions), and documented posttreatment TH. Hazard ratios (HRs) were used to compare associations between baseline MRE features, TH achievement, and long-term outcomes. Results: Baseline MRE-defined penetrating lesions were associated with increased risks of surgery (HR = 1.62, 95% CI: 1.37-1.91, Conclusion: MRE-identified penetrating/stenosing lesions at baseline predict higher risks of surgery and hospitalization. Conversely, TH achievement was associated with a marked reduction in adverse outcomes. Incorporating MRE into CD management facilitates early identification of high-risk patients for timely treatment intensification, thereby supporting personalized therapeutic strategies.

Indexed as

adult patientsclinical outcomesCrohn's diseaseinflammatory bowel diseasemagnetic resonance Enterographymeta‐analysissystematic review

Identifiers

PMID42004198
PMCPMC13086639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.